financetom
Business
financetom
/
Business
/
What's Going On With Akami Technologies Stock Monday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Akami Technologies Stock Monday?
Dec 2, 2024 9:52 AM

Akami Technologies, Inc. shares are trading higher on Monday. Oppenheimer analyst Timothy Horan upgraded Akamai ( AKAM ) from a Perform rating to an Outperform rating and announced a $120 price target.

The Details: Horan cited a stronger market environment and a robust cloud compute and edge compute platform.

In terms of a more attractive market environment, Horan highlighted that the Content Delivery Network (CDN) market has become more attractive due to reduced competition, as the number of players has decreased from six to three following the shutdown of Edgio.

Furthermore, Akamai ( AKAM ) is acquiring Edgio for approximately $150 million, including transition costs, which the analyst believes will drive revenue and margin growth, with Edgio’s revenues estimated to have 80% gross margins and 60% EBITDA margins, improving further next year.

Next, Horan highlighted strong growth in cloud compute, which is becoming an increasingly significant portion of Akamai’s revenue. Additionally, AI is driving higher demand for edge compute, while also being leveraged to enhance both security products and internal operations.

Lastly, the analyst said Akamai's ( AKAM ) cloud and edge compute platforms are positioned to benefit from the growing demand for AI inferencing and the need for AI-driven cybersecurity solutions.

Related Link: Why Bitcoin’s Institutionalization Is ‘A Concern’

AKAM Price Action: At the time of publication, Akami shares are moving 4.45% higher at $98.20, according to data from Benzinga Pro.

Image: Courtesy of Akamai Technologies, Inc. ( AKAM )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer
Sector Update: Consumer
Jun 9, 2025
08:55 AM EDT, 06/09/2025 (MT Newswires) -- Consumer stocks were edging higher pre-bell Monday as the Consumer Staples Select Sector SPDR Fund (XLP) was advancing 0.01% and Consumer Discretionary Select Sector SPDR Fund (XLY) was advancing 0.02%, recently. VinFast Auto ( VFS ) shares were up more than 10% after the company reported higher Q1 revenue. ...
Apple faces AI, regulatory challenges as it woos developers at annual conference
Apple faces AI, regulatory challenges as it woos developers at annual conference
Jun 9, 2025
* AI features delayed, rivals Google and Microsoft ( MSFT ) advance * Regulatory challenges threaten Apple's ( AAPL ) App Store fees * Smart glasses market sees Meta and Google leading By Stephen Nellis CUPERTINO, California, June 9 (Reuters) - Apple ( AAPL ) is facing an unprecedented set of technical and regulatory challenges as some of its key...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Pfizer CEO says 'no commitments' made in meetings with US government on drug pricing
Pfizer CEO says 'no commitments' made in meetings with US government on drug pricing
Jun 9, 2025
June 9 (Reuters) - Pfizer ( PFE ) and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert Bourla said on Monday. The meetings focused on high-level ideas and were not digging into any substance yet, Bourla said, speaking at Goldman Sachs' Global Healthcare Conference....
Copyright 2023-2026 - www.financetom.com All Rights Reserved